Viewing nowPioron Tablet 15 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanpavis Pharmaceutical Co., Ltd.

MFDS item code 200704287 · Approved 2007.04.12 · Insurance code 621802130
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps patients with type 2 diabetes achieve better blood glucose control. It is used in conjunction with dietary adjustments and exercise therapy, and can be administered alone or in combination with other medications. This aids in stable management of blood glucose levels.
This medicine is administered orally once daily, regardless of meals. For monotherapy, start with 15 mg once daily and increase to 30 mg once daily if the effect is insufficient. When used in combination with a sulfonylurea, metformin, or insulin, the initial dose is 15 mg once daily. The maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use.
This medication is used in the treatment of type 2 diabetes and only lowers blood glucose when insulin is also present. When taking this medication, careful attention must be paid to heart function. It may worsen or newly induce heart failure, particularly congestive heart failure; therefore, patients with heart failure or a history of heart failure should not take this medication. During treatment, observe carefully for sudden weight gain, shortness of breath, and swelling of the legs as signs of heart failure, and report any such symptoms to a doctor immediately. Additionally, this medication may cause fluid retention leading to edema; if edema worsens, consult a physician. This medication should not be administered to patients with bladder cancer or a history of bladder cancer, and immediate medical attention should be sought if hematuria or urination disorders occur. Patients with poor liver function should also exercise caution when taking this medication and should undergo regular liver function tests before and during treatment. There is a risk of hypoglycemia with this medication, so when taken with insulin or other hypoglycemic agents, patients should be vigilant for symptoms of hypoglycemia, and dose adjustments of other medications may be necessary as needed. Pregnant women or those who may become pregnant should not take this medication, and premenopausal women should use adequate contraception as this medication may stimulate ovulation. Elderly patients or those with deteriorated kidney function should be closely monitored while taking this medication. If symptoms such as sudden weight gain, edema, shortness of breath, hematuria, and urination disorders occur during treatment, consult medical personnel immediately. Finally, this medication should be taken once daily, and if a dose is missed, caution should be exercised to avoid taking double the dose the next day.
Congestive heart failure, excessive and rapid weight changes, shortness of breath, edema, fluid retention, swelling, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal bloating, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular factors, worsening of congestive heart failure, emergency room visits due to congestive heart failure, cardiovascular adverse events, dizziness, increased blood glucose, elevated ALT/AST, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle rigidity, discomfort in the head, increased liver enzymes, worsening of liver disease, hives, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, herpes simplex, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, abdominal pain, heart failure, bladder cancer, fatigue, decreased appetite, discomfort in the right upper abdomen, dark urine, jaundice, liver failure, fracture, macular edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and allows for airflow. Avoid humid areas, and it is best to store it in a cool place at a temperature between 15 to 30 degrees Celsius, particularly around 25 degrees Celsius.
A round, convex tablet that is white to grayish-white in color.
30 tablets, 300 tablets
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanpavis Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.